Impact of the 2014 American Academy of Pediatrics Policy on RSV Hospitalization in Preterm Infants in the United States

Despite being a leading cause of hospitalization due to lower respiratory tract infections, the treatment of respiratory syncytial virus (RSV) infection is primarily supportive. Palivizumab is the only licensed immunoprophylaxis (IP) available for preventing severe RSV infection in high-risk populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, Mitchell, Fergie, Jaime, Krilov, Leonard R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017053/
https://www.ncbi.nlm.nih.gov/pubmed/33656649
http://dx.doi.org/10.1007/s40121-020-00388-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017053/
https://www.ncbi.nlm.nih.gov/pubmed/33656649
http://dx.doi.org/10.1007/s40121-020-00388-1

Ejemplares similares